Bumper Offer - Urjas oil Just @ Rs. 1
Levesam 750 Tablet (10) is a prescription medicine that is available as a Tablet. Epilepsy are some of its major therapeutic uses. Secondary and off-label uses of Levesam 750 Tablet (10) have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Levesam 750 Tablet (10). Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Levesam 750 Tablet (10) are Fatigue, Headache, Drowsiness. Apart from the aforementioned side effects, Levesam 750 Tablet (10) can also lead to other problems, which have been listed below. Usually, these side effects of Levesam 750 Tablet (10) go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Levesam 750 Tablet (10) has a Moderate effect for pregnant women and Mild effect on lactating mothers. In addition, Levesam 750 Tablet (10)'s effects on the liver, heart and kidney are discussed below in the Levesam 750 Tablet (10) related warnings section.
The section on Levesam 750 Tablet (10) contraindications lists all such conditions.
Drug reaction of Levesam 750 Tablet (10) with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Levesam 750 Tablet (10) is considered not safe while driving, and is not addictive.
Levesam 750 Tablet (10) is used to treat the following -
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Levesam 750 Tablet (10) is used -
Moderate
Mild
Common
Is the use of Levesam 750 Tablet (10) safe for pregnant women?
Pregnant women may experience moderate side effects from Levesam. It is best to stop taking Levesam immediately and inform your doctor if you notice any discomfort.
Is the use of Levesam 750 Tablet (10) safe during breastfeeding?
Levesam may have very limited harmful effects for breastfeeding women.
What is the effect of Levesam 750 Tablet (10) on the Kidneys?
Very few cases of side effects of Levesam on kidney have been reported.
What is the effect of Levesam 750 Tablet (10) on the Liver?
Levesam has very mild side effects on the liver.
What is the effect of Levesam 750 Tablet (10) on the Heart?
Levesam is not harmful for the heart.
Levesam 750 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Levesam 750 Tablet (10) unless your doctor advises you to do so -
Is this Levesam 750 Tablet (10) habit forming or addictive?
Levesam 750 Tablet (10) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Levesam 750 Tablet (10) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Levesam 750 Tablet (10) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, this Levesam 750 Tablet (10) works for mental disorders.
Interaction between Food and Levesam 750 Tablet (10)
You can take Levesam 750 Tablet (10) with food.
Interaction between Alcohol and Levesam 750 Tablet (10)
Consuming Levesam 750 Tablet (10) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keppra® (levetiracetam)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 765-767
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
